Retigabine
CAS: 150812-12-7
Ref. 3D-FA61501
1g | 352.00 € | ||
2g | 530.00 € | ||
100mg | 136.00 € | ||
250mg | 188.00 € | ||
500mg | 281.00 € |
Product Information
- 2-Amino-4-(4-fluorbenzylamino)-1-ethoxycarbonylaminobenzene
- 2-Amino-4-(4-Fluorbenzylamino)-1-Ethoxycarbonylaminobenzene
- Carbamic acid, N-[2-amino-4-[[(4-fluorophenyl)methyl]amino]phenyl]-, ethyl ester
- Carbamic acid, [2-amino-4-[[(4-fluorophenyl)methyl]amino]phenyl]-, ethyl ester
- D 23129
- D2312
- Ethyl [2-amino-4-[[(4-fluorophenyl)methyl]amino]phenyl]carbamate
- Ethyl {2-Amino-4-[(4-Fluorobenzyl)Amino]Phenyl}Carbamate
- Ezogabine
- Gke 841
- See more synonyms
- Gw 582892X
- N-(2-Amino-4-(4-fluorobenzylamino)phenyl)carbamic Acid Ethyl Ester
- Potiga
- Retigabin
- RetigabineDiscontinued See: R189051
- Trobalt
- Way 143841
- [2-Amino-4-(4-fluoro-benzylamino)-phenyl]-carbamic acid ethyl ester
Retigabine is a carbamate that binds to the benzodiazepine binding site of the gamma-aminobutyric acid receptor. It has been shown to have analgesic properties in animal studies, and has also been investigated as a potential treatment for epilepsy. Retigabine may be used in combination with other drugs, such as flumazenil, which can reverse its effects. The structural analog of retigabine is flumazenil, a drug that can reverse the effects of benzodiazepines such as diazepam and midazolam. Retigabine also interacts with other drugs through significant effects on their pharmacokinetics and pharmacodynamics.
Chemical properties
Technical inquiry about: 3D-FA61501 Retigabine
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.